Translational Therapeutics, Inc. is an early-stage biopharmaceutical company commercializing targeted therapeutics & companion diagnostics for the treatment of important human cancers.

Our lead clinical candidate is a first-in-class, chemotherapeutic agent applicable to the treatment of a wide variety of human cancers including those of the breast, prostate, colon, lung, head/neck, thyroid and blood.